FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dieter Hossfeld

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Rüdiger Hehlmann; Andreas Hochhaus; Dieter K Hossfeld; Susanne Jung-Munkwitz; Stefan W Krause; Michael Lauseker; Armin Leitner; Martin C Müller; Christoph Nerl; Markus Pfirrmann; Nadine Pletsch; Hans Pralle; Ulrike Proetel; Leopold Balleisen; Alois Gratwohl; Claudia Haferlach; Mathias Hänel; Joerg Hasford; Brigitte Schlegelberger; Susanne Saussele
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
Ursula M Gehling; Marc Willems; Kathleen Schlagner; Ralf A Benndorf; Maura Dandri; Jörg Petersen; Martina Sterneck; Joerg-Matthias Pollok; Dieter K Hossfeld; Xavier Rogiers
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.
Jürgen Bruns; Günter Delling; Doris Henne-Bruns; Dieter K Hossfeld
Biopsy of tumors of the musculoskeletal system.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dieter Hossfeld (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Rüdiger Hehlmann; Andreas Hochhaus; Dieter K Hossfeld; Susanne Jung-Munkwitz; Stefan W Krause; Michael Lauseker; Armin Leitner; Martin C Müller; Christoph Nerl; Markus Pfirrmann; Nadine Pletsch; Hans Pralle; Ulrike Proetel; Leopold Balleisen; Alois Gratwohl; Claudia Haferlach; Mathias Hänel; Joerg Hasford; Brigitte Schlegelberger; Susanne Saussele
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1634-42.
2010: Ursula M Gehling; Marc Willems; Kathleen Schlagner; Ralf A Benndorf; Maura Dandri; Jörg Petersen; Martina Sterneck; Joerg-Matthias Pollok; Dieter K Hossfeld; Xavier Rogiers
Mobilization of hematopoietic progenitor cells in patients with liver cirrhosis.
World journal of gastroenterology : WJG 2010;16(2):217-24.
2008: Jürgen Bruns; Günter Delling; Doris Henne-Bruns; Dieter K Hossfeld
Biopsy of tumors of the musculoskeletal system.
Deutsches Ärzteblatt international 2008;105(27):492-7.
2008: Michael Görn; Christian R Habermann; Manuela Anige; Ina Thöm; Gunter Schuch; Birte Andritzky; Stefan Brandl; Iris Burkholder; Lutz Edler; Dieter K Hossfeld; Carsten Bokemeyer; Eckart Laack
A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC).
Onkologie 2008;31(4):185-9.
2007: Michelle Thill; Kathleen Schlagner; Sybille Altenähr; Süleyman Ergün; Richard G A Faragher; Nerbil Kilic; Jürgen Bednarz; Gaby Vohwinkel; Xavier Rogiers; Dieter K Hossfeld; Gisbert Richard; Ursula M Gehling
A novel population of repair cells identified in the stroma of the human cornea.
Stem cells and development 2007;16(5):733-45.
2007: Eckart Laack; Ina Thöm; Andreas Krüll; Walburga Engel-Riedel; Thomas Müller; Christoph Meissner; Heinz Duerk; Jürgen Fischer; Sylvia Gütz; Cornelius Kortsik; Matthias Elbers; Gunter Schuch; Birte Andritzky; Michael Görn; Iris Burkholder; Lutz Edler; Dieter K Hossfeld; Carsten Bokemeyer
A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
Lung cancer (Amsterdam, Netherlands) 2007;57(2):181-6.
2007: Sonja Loges; Martin Butzal; Jasmin Otten; Michaela Schweizer; Uta Fischer; Carsten Bokemeyer; Dieter K Hossfeld; Gunter Schuch; Walter Fiedler
Cilengitide inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.
Biochemical and biophysical research communications 2007;357(4):1016-20.
2007: Rüdiger Hehlmann; Ute Berger; Markus Pfirrmann; Hermann Heimpel; Andreas Hochhaus; Joerg Hasford; Hans-Jochem Kolb; Tanja Lahaye; Ole Maywald; Andreas Reiter; Dieter K Hossfeld; Christoph Huber; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Tobler; Christoph Nerl; Max Solenthaler; Mariele E Goebeler; Martin Griesshammer; Thomas Fischer; Stephan Kremers; Hartmut Eimermacher; Michael Pfreundschuh; Wolf-Dietrich Hirschmann; Klaus Lechner; Barbara Wassmann; Christiane Falge; Hartmut H Kirchner; Alois Gratwohl
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood 2007;109(11):4686-92.
2007: Ralf A Benndorf; Ursula M Gehling; Daniel Appel; Renke Maas; Edzard Schwedhelm; Kathleen Schlagner; Elisabeth Silberhorn; Dieter K Hossfeld; Xavier Rogiers; Rainer H Böger
Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.
Stem cells and development 2007;16(2):329-38.
2007: Djordje Atanackovic; Julia Arfsten; Yanran Cao; Sacha Gnjatic; Frank Schnieders; Katrin Bartels; Georgia Schilling; Christiane Faltz; Christine Wolschke; Judith Dierlamm; Gerd Ritter; Thomas Eiermann; Dieter K Hossfeld; Axel R Zander; Achim A Jungbluth; Lloyd J Old; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2006: Sonja Loges; Heike Tinnefeld; Anja Metzner; Manfred Jücker; Martin Butzal; Melanie Bruweleit; Uta Fischer; Elena Draab; Gunter Schuch; Anne Marie O'-Farrel; Dieter K Hossfeld; Carsten Bokemeyer; Walter Fiedler
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416.
Leukemia & lymphoma 2006;47(12):2601-9.
2006: Djordje Atanackovic; Inga Blum; Yanran Cao; Sören Wenzel; Katrin Bartels; Christiane Faltz; Dieter K Hossfeld; Susanna Hegewisch-Becker; Carsten Bokemeyer; Rudolf Leuwer
Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.
Cancer biology & therapy 2006;5(9):1218-25.
2006: Djordje Atanackovic; Kristina Pollok; Christiane Faltz; Ina Boeters; Roman Jung; Axel Nierhaus; Klaus-Michael Braumann; Dieter K Hossfeld; Susanna Hegewisch-Becker
Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes.
American journal of physiology. Regulatory, integrative and comparative physiology 2006;290(3):R585-94.
2006: Eray Goekkurt; S Hoehn; Christine Wolschke; C Wittmer; C Stueber; Dieter K Hossfeld; Jan Stoehlmacher
Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS)--novel predictors for response and survival in gastric cancer patients.
British journal of cancer 2006;94(2):281-6.
2006: Helmut Friess; Jan M Langrehr; Helmut Oettle; Jochen Raedle; Marco Niedergethmann; Christian Dittrich; Dieter K Hossfeld; Herbert Stöger; Bart Neyns; Peter Herzog; Pascal Piedbois; Frank Dobrowolski; Werner Scheithauer; Robert Hawkins; Frieder Katz; Peter Balcke; Jan Vermorken; Simon van Belle; Neville Davidson; Albert Abad Esteve; Daniel Castellano; Jörg Kleeff; Adrien A Tempia-Caliera; Andreas Kovar; Johannes Nippgen
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
BMC cancer 2006;6():285.
2005: Eckart Laack; Birte Andritzky; Heinz Duerk; Iris Burkholder; Lutz Edler; Gunter Schuch; Ina Boeters; Michael Görn; Rainer Lipp; Hartmut Horst; Johann Popp; Dieter K Hossfeld
Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer: a pilot study.
Onkologie 2005;28(12):647-50.
2005: Christine Wolschke; Eray Goekkurt; Salah-Eddin Al-Batran; Dieter K Hossfeld; Jan Stoehlmacher
Pharmacogenetics of extraordinary responses to 5-FU/cisplatin chemotherapy in advanced gastric cancer -- report of 2 cases.
Onkologie 2005;28(11):589-92.
2005: Ursula M Gehling; Marc Willems; Maura Dandri; Jörg Petersen; Marc Berna; Michelle Thill; Tina Wulf; Lars Müller; Jörg-Matthias Pollok; Kathleen Schlagner; Christiane Faltz; Dieter K Hossfeld; Xavier Rogiers
Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors.
Journal of hepatology 2005;43(5):845-53.
2005: Eckart Laack; Antje Scheffler; Iris Burkholder; Ina Boeters; Birte Andritzky; Gunter Schuch; Michael Görn; Gaby Vohwinkel; Lutz Edler; Walter Fiedler; Dieter K Hossfeld
Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2005;50(1):51-8.
2005: Georgia Schilling; Judith Dierlamm; Dieter K Hossfeld
Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.
Hematological oncology 2005;23(3-4):102-7.
2005: Djordje Atanackovic; Jens Panse; Philippe Schafhausen; Christiane Faltz; Katrin Bartels; Ina Boeters; Dieter K Hossfeld; Susanna Hegewisch-Becker
Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
Leukemia research 2005;29(9):1019-27.
2005: Gunter Schuch; Leticia Oliveira-Ferrer; Sonja Loges; Eckart Laack; Carsten Bokemeyer; Dieter K Hossfeld; Walter Fiedler; Suleyman Ergun
Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.
Leukemia 2005;19(8):1312-7.
2005: Michael Görn; Manuela Anige; Iris Burkholder; Beate Müller; Antje Scheffler; Lutz Edler; Ina Boeters; Jens Panse; Gunter Schuch; Dieter K Hossfeld; Eckart Laack
Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC).
Lung cancer (Amsterdam, Netherlands) 2005;49(1):71-6.
2005: Ute Berger; Ole Maywald; Markus Pfirrmann; Tanja Lahaye; Andreas Hochhaus; Andreas Reiter; Joerg Hasford; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Rüdiger Hehlmann
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies.
Leukemia 2005;19(6):984-9.
2005: Gunter Schuch; Maike de Wit; Jan Höltje; Eckart Laack; Georgia Schilling; Dieter K Hossfeld; Walter Fiedler; Paul Scigalla; Mark S Jacobs
Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3624-6.
2005: Sonja Loges; Gerhard Heil; Melanie Bruweleit; Volker Schoder; Martin Butzal; Uta Fischer; Ursula M Gehling; Gunter Schuch; Dieter K Hossfeld; Walter Fiedler
Analysis of concerted expression of angiogenic growth factors in acute myeloid leukemia: expression of angiopoietin-2 represents an independent prognostic factor for overall survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1109-17.
2005: Walter Fiedler; Hubert Serve; Hartmut Döhner; Michael Schwittay; Oliver G Ottmann; Anne-Marie O'Farrell; Carlo Bello; Randy Allred; William C Manning; Julie M Cherrington; Sharianne G Louie; Weiru Hong; Nicoletta M Brega; Giorgio Massimini; Paul Scigalla; Wolfgang E Berdel; Dieter K Hossfeld
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.
Blood 2005;105(3):986-93.
2005: Agnieszka Korfel; Peter Martus; Mohammad Resa Nowrousian; Dieter K Hossfeld; Heinz Kirchen; Joachim Brücher; Matthias Stelljes; Josef Birkmann; Christian Peschel; Rita Pasold; Lars Fischer; Kristoph Jahnke; Eckhard Thiel
Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
British journal of haematology 2005;128(2):177-83.
2004: Florian Langer; Ali Amirkhosravi; Sonja Loges; Todd Meyer; Barbara Eifrig; Dieter K Hossfeld; Walter Fiedler; John L Francis
An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
Thrombosis and haemostasis 2004;92(5):1136-46.
2004: Martin Butzal; Sonja Loges; Michaela Schweizer; Uta Fischer; Ursula M Gehling; Dieter K Hossfeld; Walter Fiedler
Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro.
Experimental cell research 2004;300(1):65-71.
2004: Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rübe; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Hartmut Eimermacher; Dirk Hasenclever; Norbert Schmitz; Markus Loeffler
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
Blood 2004;104(3):634-41.
2004: Michael Pfreundschuh; Lorenz Trümper; Marita Kloess; Rudolf Schmits; Alfred C Feller; Christian Rudolph; Marcel Reiser; Dieter K Hossfeld; Bernd Metzner; Dirk Hasenclever; Norbert Schmitz; Bertram Glaß; Christian Rübe; Markus Loeffler
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
Blood 2004;104(3):626-33.
2004: Georgia Schilling; Judith Dierlamm; Eva Maria Murga Penas; Kristina Hinz; Doris Seeger; Dieter K Hossfeld
Dicentric (19;21)(p13;p13), a novel chromosomal abnormality occurring in a case of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer genetics and cytogenetics 2004;152(2):129-31.
2004: Maike de Wit; Annette Raabe; B Seegers; Ralph Buchert; Hans-Peter Beck-Bornholdt; Winfried Alberti; Dieter K Hossfeld
Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.
International journal of radiation biology 2004;80(7):529-39.
2004: Gert Tuinmann; Susanna Hegewisch-Becker; Reinhart Zschaber; Andreas Kehr; Juliane Schulz; Dieter K Hossfeld
Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience.
Anti-cancer drugs 2004;15(6):575-9.
2004: Eckart Laack; N Dickgreber; Thomas Müller; A Knuth; J Benk; C Lorenz; Frank Gieseler; Heinz Duerk; Walburga Engel-Riedel; K Dalhoff; Cornelius Kortsik; U Graeven; M Burk; Thorsten Dierlamm; T Welte; Iris Burkholder; Lutz Edler; Dieter K Hossfeld
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2348-56.
2004: Sonja Loges; Boris Fehse; Marc A Brockmann; Katrin Lamszus; Martin Butzal; Markus Guckenbiehl; Gunter Schuch; Süleyman Ergün; Uta Fischer; Axel R Zander; Dieter K Hossfeld; Walter Fiedler; Ursula M Gehling
Identification of the adult human hemangioblast.
Stem cells and development 2004;13(3):229-42.
2004: Djordje Atanackovic; Andreas Block; Andreas de Weerth; Christiane Faltz; Dieter K Hossfeld; Susanna Hegewisch-Becker
Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2600-8.
2003: Martin C Müller; Norbert Gattermann; Tanja Lahaye; Michael W N Deininger; A Berndt; Stefan Fruehauf; Andreas Neubauer; Thomas Fischer; Dieter K Hossfeld; Folker Schneller; S W Krause; Christoph Nerl; Herbert G Sayer; Oliver G Ottmann; C Waller; Walter Aulitzky; Philipp le Coutre; Mathias Freund; Kirsten Merx; Peter Paschka; Heiko König; Sebastian Kreil; Ute Berger; Harald Gschaidmeier; Rüdiger Hehlmann; Andreas Hochhaus
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Leukemia 2003;17(12):2392-400.
2003: Hans-J Schmoll; Christian Kollmannsberger; Bernd Metzner; Jörg Thomas Hartmann; Norbert Schleucher; Patrick Schöffski; Jan Schleicher; Oliver Rick; Jörg Beyer; Dieter K Hossfeld; Lothar Kanz; Wolfgang E Berdel; Reinhard Andreesen; Carsten Bokemeyer
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4083-91.
2003: Eva M Murga Penas; Kristina Hinz; Kerstin Röser; Christiane Copie-Bergman; Iwona Wlodarska; Peter Marynen; Anne Hagemeijer; P Gaulard; Thomas Löning; Dieter K Hossfeld; Judith Dierlamm
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas.
Leukemia 2003;17(11):2225-9.
2003: Walter Fiedler; Rolf M Mesters; Heike Tinnefeld; Sonja Loges; Peter Staib; Ulrich Duhrsen; Michael Flasshove; Oliver G Ottmann; Wolfram Jung; Franco Cavalli; Rolf Kuse; Joerg Thomalla; Hubert Serve; Anne-Marie O'Farrell; Mark Jacobs; Nicoletta M Brega; Paul Scigalla; Dieter K Hossfeld; Wolfgang E Berdel
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia.
Blood 2003;102(8):2763-7.
2003: Ute Berger; Georg Engelich; Ole Maywald; Markus Pfirrmann; Andreas Hochhaus; Andreas Reiter; Georgia Metzgeroth; U Gnad; Joerg Hasford; Barbara Heinze; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Rüdiger Hehlmann
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Leukemia 2003;17(9):1820-6.
2003: Judith Dierlamm; Georgia Schilling; Lucienne Michaux; Kristina Hinz; Eva Maria Murga Penas; Doris Seeger; Anne Hagemeijer; Dieter K Hossfeld
Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies.
Cancer genetics and cytogenetics 2003;144(1):1-5.
2003: Susanna Hegewisch-Becker; Katharina Braun; Markus Otte; Aneta Corovic; Djordje Atanackovic; Axel Nierhaus; Dieter K Hossfeld; Klaus Pantel
Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2079-84.
2003: M Weber; Nicolaus Kröger; Florian Langer; A Hansen; Tatjana Zabelina; Barbara Eifrig; Dieter K Hossfeld; Axel R Zander
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(9):817-22.
2003: Eva Maria Murga Penas; Jan Cools; Petra Algenstaedt; Kristina Hinz; Doris Seeger; Philippe Schafhausen; Georgia Schilling; Peter Marynen; Dieter K Hossfeld; Judith Dierlamm
A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.
Genes, chromosomes & cancer 2003;37(1):79-83.
2002: Florian Langer; Barbara Eifrig; G Marx; Alexander Stork; Susanna Hegewisch-Becker; Dieter K Hossfeld
Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases.
Annals of hematology 2002;81(12):727-31.
2002: Djordje Atanackovic; Axel Nierhaus; Michael Neumeier; Dieter K Hossfeld; Susanna Hegewisch-Becker
41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
Cancer immunology, immunotherapy : CII 2002;51(11-12):603-13.
2002: Ulrich Kaiser; Irmgard Uebelacker; Ulrich Abel; Josef Birkmann; Lorenz Trümper; Harald Schmalenberg; Tunca Karakas; Bernd Metzner; Dieter K Hossfeld; Helge G Bischoff; Astrid Franke; Marcel Reiser; Peter Müller; Luisa Mantovani; Marc Grundeis; Frank Rothmann; Cay-Uwe von Seydewitz; Rolf M Mesters; Ernst U Steinhauer; Dorothea Krahl; Kurt Schumacher; Michael Kneba; Baudis Michael; Norbert Schmitz; Rüdiger Pfab; Hubert Köppler; Reza Parwaresch; Michael Pfreundschuh; Klaus Havemann
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(22):4413-9.
2002: Eckart Laack; Haleh Nikbakht; Anja Peters; Christian Kugler; Yvonne Jasiewicz; Lutz Edler; Jens Brümmer; Udo Schumacher; Dieter K Hossfeld
Expression of CEACAM1 in adenocarcinoma of the lung: a factor of independent prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4279-84.
2002: Eckart Laack; A Köhler; Christian Kugler; Thorsten Dierlamm; Claudia Knuffmann; Gaby Vohwinkel; A Niestroy; N Dahlmann; Anja Peters; J Berger; Walter Fiedler; Dieter K Hossfeld
Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(10):1550-7.
2002: M Weber; Frank Gerdsen; Kai Gutensohn; Volker Schoder; Barbara Eifrig; Dieter K Hossfeld
Enhanced platelet aggregation with TRAP-6 and collagen in platelet aggregometry in patients with venous thromboembolism.
Thrombosis research 2002;107(6):325-8.
2002: Judith Dierlamm; Eva M Murga Penas; M Daibata; H Tagushi; Kristina Hinz; Mathijs Baens; Jan Cools; Georgia Schilling; Lucienne Michaux; Peter Marynen; I Miyoshi; Dieter K Hossfeld
The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma.
Leukemia 2002;16(9):1863-4.
2002: Susanna Hegewisch-Becker; Y Gruber; A Corovic; U Pichlmeier; Djordje Atanackovic; Axel Nierhaus; Dieter K Hossfeld
Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1197-204.
2002: Florian Langer; Barbara Eifrig; Susanna Hegewisch-Becker; G Marx; K Neuber; Dieter K Hossfeld
[Complicated antiphospholid antibody syndrome].
Deutsche medizinische Wochenschrift (1946) 2002;127(27):1458-62.
2002: Florian Langer; Frauke Bergmann; Ulrich Budde; Susanna Hegewisch-Becker; Dieter K Hossfeld
Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura.
British journal of haematology 2002;118(1):271-4.
2002: Alexander Carpinteiro; Stefan Peinert; Wolfram Ostertag; Axel R Zander; Dieter K Hossfeld; Klaus Kühlcke; Hans-Georg Eckert; Christopher Baum; Susanna Hegewisch-Becker
Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.
International journal of cancer. Journal international du cancer 2002;98(5):785-92.
2002: Lalitha Iyer; Jacqueline Ramírez; Dale R Shepard; Christopher M Bingham; Dieter K Hossfeld; Mark J Ratain; Ulrich Mayer
Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice.
Cancer chemotherapy and pharmacology 2002;49(4):336-41.
2002: Eckart Laack; T Mende; Heinz Duerk; M Kneba; N Dickgreber; T Welte; Thomas Müller; J Scholtze; U Graeven; Yvonne Jasiewicz; Lutz Edler; Dieter K Hossfeld
Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
European journal of cancer (Oxford, England : 1990) 2002;38(5):654-60.
2002: Thorsten Dierlamm; Eckart Laack; Judith Dierlamm; Walter Fiedler; Dieter K Hossfeld
IgM myeloma: a report of four cases.
Annals of hematology 2002;81(3):136-9.
2002: Eckart Laack; Haleh Nikbakht; Anja Peters; Christian Kugler; Yvonne Jasiewicz; Lutz Edler; Dieter K Hossfeld; Udo Schumacher
Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor.
The American journal of pathology 2002;160(3):1001-8.
2001: Eckart Laack; T Mende; Claudia Knuffmann; Dieter K Hossfeld
Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(12):1761-3.
2001: Gert Tuinmann; Susanna Hegewisch-Becker; Dieter K Hossfeld
[New indications for thalidomide?].
Deutsche medizinische Wochenschrift (1946) 2001;126(42):1178-82.
2001: Maike de Wit; A Raabe; Gert Tuinmann; Dieter K Hossfeld
Implantable device for intravenous drug delivery in the rat.
Laboratory animals 2001;35(4):321-4.
2001: Judith Dierlamm; M Stefanova; Iwona Wlodarska; Lucienne Michaux; Kristina Hinz; Eva Maria Murga Penas; Brigitte Maes; Anne Hagemeijer; Christiane De Wolf-Peeters; Dieter K Hossfeld
Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization.
Cancer genetics and cytogenetics 2001;128(2):164-7.
2001: Eckart Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dalhoff; Thomas Müller; T Walter; Heinz Duerk; Lutz Edler; Dieter K Hossfeld
Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.
European journal of cancer (Oxford, England : 1990) 2001;37(5):583-90.
2001: Walter Fiedler; W Krüger; Eckart Laack; T Mende; Gaby Vohwinkel; Dieter K Hossfeld
A clinical trial of edrecolomab, interleukin-2 and GM-CSF in patients with advanced colorectal cancer.
Oncology reports 2001;8(2):225-31.
2001: Ulrich Dührsen; T Martinez; Gaby Vohwinkel; Süleyman Ergün; L Sun; G McMahon; Jan Dürig; Dieter K Hossfeld; Walter Fiedler
Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow.
Growth factors (Chur, Switzerland) 2001;19(1):1-17.
2001: Maike de Wit; K H Bohuslavizki; R Buchert; D Bumann; Malte Clausen; Dieter K Hossfeld
18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):29-37.
2000: G Schilling; R Lipp; Susanna Hegewisch-Becker; Dieter K Hossfeld
UFT/leucovorin plus weekly irinotecan in advanced or metastatic colorectal cancer.
Oncology (Williston Park, N.Y.) 2000;14(10 Suppl 9):38-40.
2000: Judith Dierlamm; Mathijs Baens; M Stefanova-Ouzounova; Kristina Hinz; Iwona Wlodarska; Brigitte Maes; A Steyls; A Driessen; G Verhoef; P Gaulard; Anne Hagemeijer; Dieter K Hossfeld; Christiane De Wolf-Peeters; Peter Marynen
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes.
Blood 2000;96(6):2215-8.
2000: Judith Dierlamm; M Stefanova; Iwona Wlodarska; Kristina Hinz; Brigitte Maes; Lucienne Michaux; Michel Stul; G Verhoef; J Thomas; Christiane De Wolf-Peeters; Herman Van Den Berghe; Dieter K Hossfeld; Anne Hagemeijer
Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study.
Cancer genetics and cytogenetics 2000;120(1):1-5.
2000: Mathias Hänel; Nicolaus Kröger; MM Hoffknecht; S O Peters; Bernd Metzner; Friedrich Fiedler; Dietrich Braumann; J C Schubert; Hans-Jochen Illiger; Annette Hänel; William H Krüger; W Zeller; HJ Weh; Dieter K Hossfeld; Axel R Zander
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Annals of hematology 2000;79(6):304-11.
2000: M Stefanova; Judith Dierlamm; Lucienne Michaux; P Leberecht; Doris Seeger; Kristina Hinz; Dieter K Hossfeld
Polysomy 13 with concomitant deletion of 13q13-14 involving the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia.
Cancer genetics and cytogenetics 2000;119(2):158-61.
2000: Ursula M Gehling; Süleyman Ergün; U Schumacher; Christoph Wagener; K Pantel; M Otte; Gunter Schuch; Philippe Schafhausen; T Mende; Nerbil Kilic; K Kluge; B Schäfer; Dieter K Hossfeld; Walter Fiedler
In vitro differentiation of endothelial cells from AC133-positive progenitor cells.
Blood 2000;95(10):3106-12.
2000: Judith Dierlamm; Iwona Wlodarska; Lucienne Michaux; M Stefanova; Kristina Hinz; Herman Van Den Berghe; Anne Hagemeijer; Dieter K Hossfeld
Genetic abnormalities in marginal zone B-cell lymphoma.
Hematological oncology 2000;18(1):1-13.
2000: Walter Fiedler; R P Henke; S Ergün; U Schumacher; Ursula M Gehling; Gaby Vohwinkel; Nerbil Kilic; Dieter K Hossfeld
Derivation of a new hematopoietic cell line with endothelial features from a patient with transformed myeloproliferative syndrome: a case report.
Cancer 2000;88(2):344-51.
1999: Rüdiger Hehlmann; Andreas Hochhaus; Hans-Jochem Kolb; Joerg Hasford; Alois Gratwohl; Hermann Heimpel; Wolfgang Siegert; J Finke; Gerhard Ehninger; E Holler; Ute Berger; Markus Pfirrmann; A Muth; Axel Zander; A A Fauser; A Heyll; Christoph Nerl; Dieter K Hossfeld; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Tobler
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
Blood 1999;94(11):3668-77.
1999: Ullrich Graeven; Walter Fiedler; S Karpinski; Süleyman Ergün; Nerbil Kilic; Ulrich Rodeck; Wolff Schmiegel; Dieter K Hossfeld
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR.
Journal of cancer research and clinical oncology 1999;125(11):621-9.
1999: Judith Dierlamm; Lucienne Michaux; M Stefanova; J Eggert; P Leberecht; Doris Seeger; M Westerhausen; Dieter K Hossfeld
Novel Philadelphia variant t(Y;9;22)(q12;q34;q11) in a case of chronic myeloid leukemia.
Cancer genetics and cytogenetics 1999;114(2):150-3.
1999: W Zeller; Nicolaus Kröger; J Berger; William Krueger; Judith Dierlamm; Marcus Stockschläder; Kai Gutensohn; Dieter K Hossfeld; Axel R Zander
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
Journal of hematotherapy & stem cell research 1999;8(5):539-46.
1999: Judith Dierlamm; M Stefanova; Lucienne Michaux; E Lincke; P Leberecht; Dieter K Hossfeld
Unusual clinical course and acquisition of del(11)(q23) in second lymphatic blastic phase of a Ph-positive chronic myeloid leukemia.
Cancer genetics and cytogenetics 1999;113(1):85-9.
1999: W Zhang; G Knieling; Gaby Vohwinkel; T Martinez; Rolf Kuse; Dieter K Hossfeld; Ulrich Dührsen
Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia.
Annals of hematology 1999;78(7):305-14.
1999: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Winfried Gassmann; Torsten Haferlach; Christa Fonatsch; Detlef Haase; Claudia Schoch; Dieter K Hossfeld; Eva Lengfelder; Carlo Aul; Axel Heyll; Georg Maschmeyer; Wolf-Dieter Ludwig; Maria Cristina Sauerland; Achim Heinecke
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.
Blood 1999;93(12):4116-24.
1999: Judith Dierlamm; Mathijs Baens; Iwona Wlodarska; M Stefanova-Ouzounova; J M Hernandez; Dieter K Hossfeld; Christiane De Wolf-Peeters; Anne Hagemeijer; Herman Van Den Berghe; Peter Marynen
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas.
Blood 1999;93(11):3601-9.
1998: Wolfgang Kern; Jan Braess; A Grote-Metke; H Kuse; R Fuchs; Dieter K Hossfeld; Albrecht Reichle; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial. German AML Cooperative Group.
Leukemia 1998;12(10):1522-6.
1998: Wolf-Dieter Ludwig; Harald Rieder; Claus R Bartram; Barbara Heinze; Stefan Schwartz; Winfried Gassmann; Helmut Löffler; Dieter K Hossfeld; Gerhard Heil; S Handt; Axel Heyll; Helmut Diedrich; K Fischer; A Weiss; B Völkers; U Aydemir; Christa Fonatsch; Nicola Gökbuget; Eckhard Thiel; Dieter Hoelzer
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.
Blood 1998;92(6):1898-909.
1998: Carsten Bokemeyer; Andreas Harstrick; Jörg Beyer; Bernd Metzner; U Rüther; J T Hartmann; K Holstein; Hans Günter Derigs; R de Wit; J Casper; Patrick Schöffski; I Kührer; Hans-Jochen Illiger; B Kempf; A Reichle; A Föller; Dieter K Hossfeld; J T Fischer; W E Berdel; H H Gerhartz; H Kirchner; K H Pflüger; Helmut Ostermann; Lothar Kanz; H J Schmoll
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Seminars in oncology 1998;25(2 Suppl 4):24-32; discussion 45-8.
1998: Susanna Hegewisch-Becker; F Staib; T Löning; U Pichlmeier; N Kröger; A Reymann; Dieter K Hossfeld
No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(1):85-93.
1997: Claudia Schoch; Detlef Haase; Christa Fonatsch; Torsten Haferlach; Helmut Löffler; Brigitte Schlegelberger; Dieter K Hossfeld; R Becher; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group.
British journal of haematology 1997;99(3):605-11.
1997: U Dührsen; V Heinrichs; W D Beecken; K Herbst; K Mross; Dieter K Hossfeld
Local and systemic sequelae of mediastinal daunorubicin extravasation in a patient with acute myelomonocytic leukemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(11):1167-8.
1997: W Fielder; Ullrich Graeven; Süleyman Ergün; S Verago; Nerbil Kilic; Marcus Stockschläder; Dieter K Hossfeld
Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia.
Leukemia 1997;11(8):1234-7.
1997: G Shi; HJ Weh; U Dührsen; W Zeller; Dieter K Hossfeld
Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies.
Cancer genetics and cytogenetics 1997;96(1):58-63.
1997: G Shi; HJ Weh; Dieter K Hossfeld
Reinterpretation of G-banded complex karyotypes by fluorescence in situ hybridization with chromosome-specific DNA painting probes and alpha-satellite centromere-specific DNA probes in malignant hematological disorders.
American journal of hematology 1997;55(2):69-76.
1997: Rüdiger Hehlmann; Andreas Willer; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Andreas Hochhaus; Andreas Tobler; Eva Lengfelder; Ute Berger; Christine Leib-Mösch
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.
Leukemia 1997;11 Suppl 3():506-11.
1997: Rüdiger Hehlmann; H Ansari; Joerg Hasford; Hermann Heimpel; Dieter K Hossfeld; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Reiter; Andreas Hochhaus
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group.
British journal of haematology 1997;97(1):76-85.
1997: T A Walter; HJ Weh; P M Schlag; C Zornig; Dieter K Hossfeld
Cytogenetic studies in malignant fibrous histiocytoma.
Cancer genetics and cytogenetics 1997;94(2):131-4.
1997: Walter Fiedler; Ullrich Graeven; Süleyman Ergün; S Verago; Nerbil Kilic; Marcus Stockschläder; Dieter K Hossfeld
Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia.
Blood 1997;89(6):1870-5.
1997: Maike de Wit; D Bumann; W Beyer; K Herbst; Malte Clausen; Dieter K Hossfeld
Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():57-60.
1996: Marcus Stockschläder; W Fiedler; Axel Zander; HJ Weh; Dieter K Hossfeld
Philadelphia chromosome-positive secondary acute myeloid leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma.
Annals of hematology 1996;73(6):291-3.
1996: Axel R Zander; W Krüger; Nicolaus Kröger; L Damon; M Königmann; W E Berdel; F Gieseking; K Schäfer-Eckart; V Möbus; N Frickhofen; Hannes Wandt; Hans-Jochen Illiger; Bernd Metzner; K Kolbe; B Wörmann; L Trümper; C Huber; Dieter K Hossfeld; H Maass; W Jonat
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Bone marrow transplantation 1996;18 Suppl 1():S24-5.
1996: Rüdiger Hehlmann; Hermann Heimpel; Dieter K Hossfeld; Joerg Hasford; Hans-Jochem Kolb; Helmut Löffler; Hans Pralle; Wolfgang Queisser; Andreas Hochhaus; A Tichelli; W Fett; Norbert Schmitz; A Reiter; Martin Griesshammer; W Pfeifer; M Bümler; T Kamp; Andreas Tobler; Hartmut Eimermacher; R Kuse; Ute Berger; H Ansari
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S21-4.
1996: Susanna Hegewisch-Becker; Dieter K Hossfeld
The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives.
Annals of hematology 1996;72(3):105-17.
1996: HJ Weh; P Jonveaux; D Seeger; J Felgner; Dieter K Hossfeld
t(1;19)(q23;p13) in a case of acute monocytic leukemia.
Cancer genetics and cytogenetics 1996;87(1):52-4.
1996: HJ Weh; D Seeger; I Junge; Dieter K Hossfeld
Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia.
Annals of hematology 1996;72(2):81-2.
1996: Dieter Hoelzer; Wolf-Dieter Ludwig; Eckhard Thiel; Winfried Gassmann; Helmut Löffler; Christa Fonatsch; Harald Rieder; Gerhard Heil; Barbara Heinze; R Arnold; Dieter K Hossfeld; Thomas Büchner; P Koch; Mathias Freund; Wolfgang Hiddemann; Georg Maschmeyer; Axel Heyll; Carlo Aul; T Faak; R Kuse; T H Ittel; M Gramatzki; Helmut Diedrich; K Kolbe; H G Fuhr; K Fischer; C Schadeck-Gressel; A Weiss; I Strohscheer; Bernd Metzner; U Fabry; Nicola Gökbuget; B Völkers; D Messerer; K Uberla
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Blood 1996;87(2):495-508.
1996: K Mross; J Reifke; P Bewermeier; W Kruger; Dieter K Hossfeld; Axel Zander
The pharmacokinetics and toxicity of two application schedules with high-dose VP-16 in patients receiving an allogeneic bone marrow transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):83-8.
1996: G Shi; HJ Weh; S Martensen; D Seeger; Dieter K Hossfeld
3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia.
Cytogenetics and cell genetics 1996;74(4):295-9.
1996: K Mross; A Hüttmann; K Herbst; Axel R Hanauske; T Schilling; C Manegold; K Burk; Dieter K Hossfeld
Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611. A study by the AIO groups PHASE-I and APOH.
Cancer chemotherapy and pharmacology 1996;38(3):217-24.
1996: S Hegewisch-Becker; C Faltz; Dieter K Hossfeld
Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
European journal of haematology 1996;56(1-2):12-22.
1995: HJ Weh; R Bartl; D Seeger; J Selbach; R Kuse; Dieter K Hossfeld
Correlations between karyotype and cytologic findings in multiple myeloma.
Leukemia 1995;9(12):2119-22.
1995: S O Peters; Marcus Stockschläder; Susanna Hegewisch-Becker; W Krüger; H J Weh; Dieter K Hossfeld; Axel R Zander
Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bone marrow transplantation 1995;15(5):783-4.
1995: J Decker; W Fiedler; A Samalecos; Dieter K Hossfeld
Absence of point mutations in the extracellular domain of the alpha subunit of the GM-CSF receptor in a series of patients with acute myeloid leukemia (AML).
Leukemia 1995;9(1):185-8.
1994: Rüdiger Hehlmann; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Andreas Hochhaus; Barbara Heinze
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Blood 1994;84(12):4064-77.
1994: K Mross; P Bewermeier; W Krüger; Marcus Stockschläder; Axel Zander; Dieter K Hossfeld
Pharmacokinetics of undiluted or diluted high-dose etoposide with or without busulfan administered to patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(7):1468-74.
1994: K Mross; P Bewermeier; J Reifke; W Krüger; Marcus Stockschläder; Axel Zander; Dieter K Hossfeld
Pharmacokinetics of high-dose VP-16: 6-hour infusion versus 34-hour infusion.
Bone marrow transplantation 1994;13(4):423-30.
1994: M Arland; W Fiedler; A Samalecos; Dieter K Hossfeld
Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML).
Leukemia 1994;8(3):498-501.
1993: A Hüttmann; K Mross; Dieter K Hossfeld
Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detection.
Journal of chromatography 1993;620(2):233-8.
1993: G Shi; HJ Weh; Dieter K Hossfeld
Translocation (2;4)(p23;q25): an additional case of a new recurrent anomaly in acute myeloid leukemia.
Cancer genetics and cytogenetics 1993;70(2):140-1.
1993: S Suciu; W Zeller; HJ Weh; Dieter K Hossfeld
Immunophenotype of mitotic cells with clonal chromosome abnormalities demonstrating multilineage involvement in acute myeloid leukemia.
Cancer genetics and cytogenetics 1993;70(1):1-5.
1993: Susanna Hegewisch-Becker; A Szudra; Dieter K Hossfeld
Exposure to lipophilic industrial solvents leads to increased P-glycoprotein expression in peripheral blood cells.
British journal of haematology 1993;85(1):220-2.
1993: Rüdiger Hehlmann; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Barbara Heinze; A Georgii
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
Blood 1993;82(2):398-407.
1993: W Fiedler; H J Weh; Susanna Hegewisch-Becker; Dieter K Hossfeld
GCSF gene is expressed but not rearranged in a patient with isochromosome 17q positive acute nonlymphocytic leukemia.
Cancer genetics and cytogenetics 1993;68(1):49-51.
1993: Susanna Hegewisch-Becker; M Fliegner; T Tsuruo; Axel Zander; W Zeller; Dieter K Hossfeld
P-glycoprotein expression in normal and reactive bone marrows.
British journal of cancer 1993;67(3):430-5.
1993: K Mross; C Bohn; L Edler; W Jonat; W Queisser; E Heidemann; M Goebel; Dieter K Hossfeld
Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):45-50.
1993: K Mross; K Hamm; Dieter K Hossfeld
Effects of verapamil on the pharmacokinetics and metabolism of epirubicin.
Cancer chemotherapy and pharmacology 1993;31(5):369-75.
1993: HJ Weh; Kai Gutensohn; J Selbach; R Kruse; G Wacker-Backhaus; D Seeger; W Fiedler; W Fett; Dieter K Hossfeld
Karyotype in multiple myeloma and plasma cell leukaemia.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1269-73.
1992: Kai Gutensohn; HJ Weh; T A Walter; Dieter K Hossfeld
Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.
Annals of hematology 1992;65(2):88-90.
1992: T A Walter; Ulrich Müllerleile; I Galinke; HJ Weh; Dieter K Hossfeld
A case of adult ALL with +i(13q) as the sole anomaly.
Cancer genetics and cytogenetics 1992;60(2):193-4.
1992: W Fiedler; HJ Weh; Dieter K Hossfeld
Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma.
British journal of haematology 1992;81(1):58-61.
1992: Rüdiger Hehlmann; Hermann Heimpel; Martin Griesshammer; Hans-Jochem Kolb; Barbara Heinze; Dieter K Hossfeld; P D Wickramanayake; U Essers; J Thiele; A Georgii
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
Leukemia 1992;6 Suppl 3():110S-114S.
1992: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Georg Maschmeyer; Dieter K Hossfeld; Wolf-Dieter Ludwig; M Nowrousian; Carlo Aul; U W Schaefer
Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML: data from AMLCG.
Leukemia 1992;6 Suppl 2():68-71.
1992: K Mross; K Hamm; Wolfgang Schultze-Seemann; K Burk; Dieter K Hossfeld
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors.
Cancer chemotherapy and pharmacology 1992;29(6):490-4.
1991: W Fiedler; HJ Weh; W Zeller; C Fonatsch; J Hillion; C Larsen; B Wörmann; Dieter K Hossfeld
Translocation (14; 18) and (8; 22) in three patients with acute leukemia/lymphoma following centrocytic/centroblastic non-Hodgkin's lymphoma.
Annals of hematology 1991;63(5):282-7.
1991: Thomas Büchner; Wolfgang Hiddemann; G Löffler; Winfried Gassmann; Georg Maschmeyer; W Heit; Dieter K Hossfeld; H Weh; Wolf-Dieter Ludwig; Eckhard Thiel
Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group.
Seminars in hematology 1991;28(3 Suppl 4):76-9.
1991: Rüdiger Hehlmann; H Heimpel; Barbara Heinze; A Georgii; Hans-Jochem Kolb; Dieter K Hossfeld; P von Wussow; Andreas Hochhaus; Martin Griesshammer; V Diehl
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)].
Onkologie 1991;14(1):66-73.
1990: K Mross; U Mayer; K Hamm; Dieter K Hossfeld
High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samples.
Journal of chromatography 1990;530(1):192-9.
1990: W Fiedler; E Suciu; C Wittlief; W Ostertag; Dieter K Hossfeld
Mechanisms of growth factor expression in acute myeloid leukemia (AML).
Leukemia 1990;4(7):459-61.
1990: W Fiedler; HJ Weh; E Suciu; C Wittlief; C Stocking; Dieter K Hossfeld
The IL-6 gene but not the IL-6 receptor gene is occasionally rearranged in patients with multiple myeloma.
Leukemia 1990;4(7):462-5.
1990: HJ Weh; R Kuse; Dieter K Hossfeld
Acute nonlymphocytic leukemia (ANLL) with isochromosome i(17q) as the sole chromosomal anomaly: a distinct entity?
European journal of haematology 1990;44(5):312-4.
1990: HJ Weh; J Selbach; W Fielder; Dieter K Hossfeld
An identical translocation t(1;20) (q12.3;p13) in two patients with multiple myeloma.
British journal of haematology 1990;74(3):365-7.
1990: T Langenbuch; K Mross; W Jonat; Dieter K Hossfeld
A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.
Cancer chemotherapy and pharmacology 1990;26 Suppl():S93-6.
1990: K Mross; U Mayer; T Langenbuch; K Hamm; K Burk; Dieter K Hossfeld
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients.
European journal of cancer (Oxford, England : 1990) 1990;26(11-12):1156-62.
1990: K Mross; U Mayer; K Hamm; K Burk; Dieter K Hossfeld
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.
European journal of clinical pharmacology 1990;39(5):507-13.
1988: HJ Weh; R Hoffmann; S Suciu; R Kuse; Dieter K Hossfeld
Is trisomy 11 another nonrandom chromosomal anomaly in acute nonlymphocytic leukemia and myelodysplastic syndromes?
Cancer genetics and cytogenetics 1988;35(2):205-11.
1988: S Suciu; HJ Weh; R Kuse; C B Meier; Dieter K Hossfeld
Trisomy 4 in two cases of acute myelomonocytic leukemia.
Cancer genetics and cytogenetics 1988;33(1):19-23.
1988: HJ Weh; R Kuse; R Hoffmann; D Seeger; S Suciu; H Kabisch; J Ritter; Dieter K Hossfeld
Prognostic significance of chromosome analysis in de novo acute myeloid leukemia (AML).
Blut 1988;56(1):19-26.
1987: HJ Weh; A Calavrezos; D Seeger; R Kuse; Dieter K Hossfeld
Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS).
European journal of haematology 1987;38(2):166-72.
1987: A von Paleske; Ulrich Müllerleile; V Gressler; M Garbrecht; Dieter K Hossfeld
Incidence and treatment of fungal infections in neutropenic patients.
Haematology and blood transfusion 1987;30():545-6.
1985: V Gressler; M Garbrecht; Dieter K Hossfeld
Occurrence of the common acute lymphoblastic leukemia antigen on blast cells of a patient with chronic myelomonocytic leukemia in non-lymphoid blastic phase.
Blood 1985;66(6):1482-4.
1982: Thomas Büchner; D Urbanitz; B Emmerich; J Th Fischer; H H Fülle; Achim Heinecke; Dieter K Hossfeld; K M Koeppen; L Labedzki; Helmut Löffler; M R Nowrousian; M Pfreundschuh; Hans Pralle; H Rühl; F C Wendt
Multicentre study on intensified remission induction therapy for acute myeloid leukemia.
Leukemia research 1982;6(6):827-31.